Clinical Trial Update: RECOVER-SLEEP: Platform Protocol [Phase 2]

View source ↗

Summary

The RECOVER-SLEEP platform protocol (Phase 2) for evaluating sleep disturbances in Long COVID patients has completed its Phase 2 trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypersomnia
• Long Covid
• Sleep Disturbance

Snippet

Sponsor: Duke University | Conditions: Long COVID, Long COVID-19 | Phase 2 | Status: COMPLETED